Freedom Meditech was incorporated in December 2006. The Company was formed based on the following activities;
- Due diligence on numerous early-stage medical device technologies
- Related research
- Intellectual property (IP) evaluation
- Management and advisor recruiting
- Product development planning
- Licensing negotiations
- Business development activities
Freedom Meditech has been founded with the goal of licensing, developing, and commercializing non-invasive biophotonic technologies with clear market needs and overall global appeal.
In December 2006 the Company initially in-licensed non-invasive glucose monitoring technology for the University of Toledo.
In February 2009 the Company performed a product line acquisition from Guided Therapeutics, Inc. (OTCBB: GTHP). The acquisition included intellectual property, fully engineered prototypes and validation studies.
The Company has been financed through angel and a Series A venture capital funding and most recently through Series B-1 convertible debt securities.